1 / 27

HYPERTENSION

HYPERTENSION. Sustained hypertension can damage blood vessels in kidney, brain and heart = incidence of renal failure, cardiac failure and stroke. Normal BP control mechanisms. Renin –angiotensin –aldosterone system Baroreceptor reflex. Stage. Diastolic Range (mm Hg). Systolic Range (mm Hg).

pglisson
Download Presentation

HYPERTENSION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HYPERTENSION

  2. Sustained hypertension can damage blood vessels in kidney, brain and heart = incidence of renal failure, cardiac failure and stroke

  3. Normal BP control mechanisms • Renin –angiotensin –aldosterone system • Baroreceptor reflex

  4. Stage Diastolic Range (mm Hg) Systolic Range (mm Hg) High Normal 85-89 130-139 Stage 1 90-99 140-159 Stage 2 100-109 160-179 Stage 3 > 109 >179

  5. Na+ Na+ Drugs acting on therenin-angiotensin system. arteries Angiotensinogen AI AII Renin adrenal glands Aldosterone kidneys

  6. Drugs acting on therenin-angiotensin system arteries Angiotensinogen AI AII Renin adrenal glands Aldosterone kidneys Na+ Na+

  7. ACE Inhibitors AIIRA Calcium Blockers Diuretics Beta-blockers Spironolactone Drugs acting on therenin-angiotensin system. arteries Angiotensinogen AI AII Renin adrenal glands Aldosterone kidneys

  8. Diuretics • Thiazides, loop diuretics, potassium sparing diuretics

  9. ACE inhibitors/ ARB • Captopril, enalapril, ramipril, lisinopril • Losartan, valsartan, irbesartan

  10. Beta blockers • Atenolol, metaprolol, carvedilol, labetalol

  11. Calcium channel blockers • Verapamil, diltiazem, nifedipine, amlodipine

  12. a-blockers • Mechanism of action: blockade of vascular a -adrenoceptors • Non selective (a1 and a2) blockers: Phentolamine, phenoxybenzamine and dibenamine • Selective (a1: prazosin,terazosin, doxazosin, trimazosin)

  13. Hydralazine • Direct acting vasodilator: liberates NO from vascular endothelium which stimulates the production of cGMP in vascular smooth muscle, resulting in relaxation (arterioles > veins) • Can NOT be used for monotherapy • Tachycardia with palpitations, hypotension , nausea, vomiting, sweating, Lupus erythmatosis • Never use as first choice; Try in refractory hypertension as part of a multidrug regimen

  14. Minoxidil • Prodrug of minoxidil sulfate, which is a direct acting vasodilator • Mechanism: K+ channel opener, causes membrane hyperpolarization, reducing ability of smooth muscle to contract. • Other K channel openers: pinacidil, diazoxide • refractory hypertension • Long duration of action (>24 hours)

  15. Minoxidil Adverse Effects • Fluid and water retention: can lead to pulmonary hypertension • Tachycardia and increased cardiac output: • Headache, sweating, hirsutism

  16. DIAZOXIDE • occasionally - hypertensive emergencies. • opening potassium channels • half-life; 24 hours, rapid injection onset 5 minutes lasts 4-12 hours • hypotension→ stroke and myocardial infarction / provoke angina, cardiac failure in patients with ischemic heart disease → when dose of 300 mg is used; instead infuse at 15-30 mg/min • avoided in IHD • inhibits insulin release → used to treat hypoglycemia secondary toinsulinoma

  17. SODIUM NITROPRUSSIDE • hypertensive emergencies as well as severe heart failure • dilates both arterial and venousvessels, ↓ PVR & venous return - cardiac output decreases • activation of guanylylcyclase -relaxesvascular smooth muscle • In heart failure and low cardiac output, output often increases owing to afterload reduction

  18. Rapid & short acting 1- 10 minutes on discontinuation - IV infusion • Metabolic acidosis, arrhythmias, hypotension • methemoglobunemia

  19. FENOLDOPAM • D1 agonist peripheral arteries and natriuresis= hypertensive emergencies and postoperative hypertension. • rapidly metabolized conjugation half-life 10 minutes continuous intravenous infusion. • Reflex tachycardia, flushing, headache increases intraocular pressureavoid in glaucoma

  20. Centrally Acting Sympatholytics:a2-Adrenoceptor Agonists • a-Methyldopa • Clonidine

  21. a2-Adrenoceptor Agonists Mechanisms of Action • Central Action: Stimulation of a2 adrenoceptors in the brainstem reduces sympathetic tone, causing a centrally mediated vasodilatation and reduction in heart rate • Prejunctional action: Stimulation of a2 adrenoceptors located prejunctionally on peripheral neurons reduces norepinephrine release

  22. Clonidine • Partial agonist - a2A • Lipid soluble, short half life. • Dry mouth, sedation, salt & water retention, hypotension, • Sudden withdrawal = hypertensive crises • Moderately potent antihypertensive

  23. Methyldopa • Mild to moderately severe HT • ↓ PVR, ↓ CO & HR, ↓ renal vascular resistance. • Sedation, orthostatic hypertension, impaired mental conc. , lactation, nightmares, mental depression, fluid retention.

  24. Reserpine Molecular mechanism of action: Inhibition of noradrenergic function. • Interferes with uptake mechanism, Storage vesicles are destroyed and nerve ending loses capacity to store and release norepinephrine and serotonin • Pharmacological consequences: reduction of cardiac output and TPR

  25. Reserpine • Extremely long acting • Mild to moderate HT • Postural hypotension, diarrhoea, abdominal cramps • CNS effects: • Sedation, loss of concentration • psychotic depression. • Extrapyramidal effects

  26. Guanithidine • Sympathoplegic • Inhibits release release of NA from sympathetic nerve ending. • Long half life (5 days) • Hypotension, diarrhoea, delayed or retrograde ejaculation

More Related